Electronic Fetal Heart Rate Monitoring: The Future

ISSN: 1875-6581 (Online)
ISSN: 1573-4048 (Print)

Volume 13, 2 Issues, 2017

Download PDF Flyer

Current Women's Health Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

John Yeh
Harvard Medical School
Department of Obstetrics and Gynecology
Massachusetts General Hospital
Boston, MA

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Electronic Fetal Heart Rate Monitoring: The Future

Current Women's Health Reviews, 9(3): 169-174.

Author(s): Taran Khangura and Edwin Chandraharan.

Affiliation: Consultant Obstetrician and Gynaecologist, St. George’s Healthcare NHS Trust, Blackshaw Road, London SW 17 0RE, UK.


Continuous electronic fetal heart rate monitoring (EFM) using a cardiotocograph (CTG) is associated with a high false positive rate of approximately 60%. Current scientific evidence does not support a significant reduction in perinatal mortality or cerebral palsy, except for a 50% reduction in neonatal convulsions. Recent scientific evidence has questioned the role of ‘peripheral’ tests of fetal wellbeing such as fetal scalp blood sampling (FBS), fetal scalp lactate and fetal pulse oximetry in reducing the false positive rate of CTG. Fetal ECG (ST-Analyzer or STAN) shows promise in reducing neonatal admissions and operative vaginal births. Computerized CTG analysis and Fetal Physiological Score (FPS) may help reduce errors associated with CTG interpretation.


Fetal scalp blood sampling, fetal scalp lactate, ST-Analyzer (STAN), Fetal Physiological Score (FPS), computerised analysis.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 3
First Page: 169
Last Page: 174
Page Count: 6
DOI: 10.2174/157340480903140131111807
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science